Our findings also imply a novel inter-organ network between kidney and PRAT, possibly mediated by leptin, for the development of DN, and thus suggests new clinical implications for the prevention and treatment of DN through pharmacological intervention. This evidence concerns the gene PPAT and liver dysplastic nodule.